EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. BCRX

Equity Profile

BCRX

BioCryst Pharmaceuticals, Inc.

Health CareBiotechnology$2.1B market cap

Earnings scorecard

Last 76Q

EPS beat streak

1Q

EPS beat rate

54%

Avg EPS surprise

-24.25%

Avg 1-day reaction

-2.07%

Earnings history

77 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingNov 2, 2026$0.12———Preview
Q2-2026Aug 5, 2026$0.23$0.30+109.79%+0.55%Preview
Q1-2026May 6, 2026$0.11$-2.98-5066.67%-2.21%Preview
Q4-2025Feb 26, 2026$0.07$1.12+1623.08%+4.64%Preview
Q3-2025Nov 3, 2025$0.07$0.16+116.22%-6.28%Preview
Q2-2025Aug 4, 2025ProPreview
Q1-2025May 5, 2025ProPreview
Q4-2024Feb 24, 2025ProPreview
Q3-2024Nov 4, 2024ProPreview
Q2-2024Aug 5, 2024ProPreview
Q1-2024May 6, 2024ProPreview
Q4-2023Feb 26, 2024ProPreview
Q3-2023Nov 2, 2023ProPreview
Q2-2023Aug 3, 2023ProPreview
Q1-2023May 3, 2023ProPreview
Q4-2022Feb 21, 2023ProPreview
Q3-2022Nov 1, 2022ProPreview
Q2-2022Aug 4, 2022ProPreview
Q1-2022May 5, 2022ProPreview
Q4-2021Feb 23, 2022ProPreview
Q3-2021Nov 3, 2021ProPreview
Q2-2021Aug 5, 2021ProPreview
Q1-2021May 6, 2021ProPreview
Q4-2020Feb 25, 2021ProPreview
Q3-2020Nov 5, 2020ProPreview
Q2-2020Aug 6, 2020ProPreview
Q1-2020May 6, 2020ProPreview
Q4-2019Mar 5, 2020ProPreview
Q3-2019Nov 6, 2019ProPreview
Q2-2019Aug 6, 2019ProPreview
Q1-2019May 8, 2019ProPreview
Q4-2018Mar 4, 2019ProPreview
Q3-2018Nov 6, 2018ProPreview
Q2-2018Aug 7, 2018ProPreview
Q1-2018May 8, 2018ProPreview
Q4-2017Feb 27, 2018ProPreview
Q3-2017Nov 7, 2017ProPreview
Q2-2017Aug 7, 2017ProPreview
Q1-2017May 4, 2017ProPreview
Q4-2016Feb 27, 2017ProPreview
Q3-2016Nov 7, 2016ProPreview
Q2-2016Aug 4, 2016ProPreview
Q1-2016May 5, 2016ProPreview
Q4-2015Feb 23, 2016ProPreview
Q3-2015Nov 5, 2015ProPreview
Q2-2015Aug 7, 2015ProPreview
Q1-2015May 8, 2015ProPreview
Q4-2014Feb 18, 2015ProPreview
Q3-2014Nov 6, 2014ProPreview
Q2-2014Aug 5, 2014ProPreview
Q1-2014May 8, 2014ProPreview
Q4-2013Feb 26, 2014ProPreview
Q3-2013Nov 5, 2013ProPreview
Q2-2013Aug 8, 2013ProPreview
Q1-2013May 7, 2013ProPreview
Q4-2012Feb 19, 2013ProPreview
Q3-2012Nov 8, 2012ProPreview
Q2-2012Aug 2, 2012ProPreview
Q1-2012May 7, 2012ProPreview
Q4-2011Feb 16, 2012ProPreview
Q3-2011Nov 2, 2011ProPreview
Q2-2011Aug 4, 2011ProPreview
Q1-2011May 4, 2011ProPreview
Q4-2010Feb 10, 2011ProPreview
Q3-2010Oct 28, 2010ProPreview
Q2-2010Aug 5, 2010ProPreview
Q1-2010Apr 28, 2010ProPreview
Q4-2009Feb 4, 2010ProPreview
Q3-2009Oct 29, 2009ProPreview
Q2-2009Jul 30, 2009ProPreview
Q1-2009May 8, 2009ProPreview
Q4-2008Feb 6, 2009ProPreview
Q3-2008Oct 31, 2008ProPreview
Q2-2008Aug 7, 2008ProPreview
Q1-2008May 8, 2008ProPreview
Q4-2007Mar 4, 2008ProPreview
Q3-2007Nov 8, 2007ProPreview

Next report

Q3-2026

Mon, Nov 2

Before the open

Est. EPS

$0.12

Est. Rev

$166M

Read the preview

About BCRX

Sector
Health Care
Industry
Biotechnology
Market cap
$2.1B

72 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Aug 4, 2025ProPreview
Q1-2025May 5, 2025ProPreview
Q4-2024Feb 24, 2025Pro
Preview
Q3-2024Nov 4, 2024ProPreview
Q2-2024Aug 5, 2024ProPreview
Q1-2024May 6, 2024ProPreview
Q4-2023Feb 26, 2024ProPreview
Q3-2023Nov 2, 2023ProPreview
Q2-2023Aug 3, 2023ProPreview
Q1-2023May 3, 2023ProPreview
Q4-2022Feb 21, 2023ProPreview
Q3-2022Nov 1, 2022ProPreview
Q2-2022Aug 4, 2022ProPreview
Q1-2022May 5, 2022ProPreview
Q4-2021Feb 23, 2022ProPreview
Q3-2021Nov 3, 2021ProPreview
Q2-2021Aug 5, 2021ProPreview
Q1-2021May 6, 2021ProPreview
Q4-2020Feb 25, 2021ProPreview
Q3-2020Nov 5, 2020ProPreview
Q2-2020Aug 6, 2020ProPreview
Q1-2020May 6, 2020ProPreview
Q4-2019Mar 5, 2020ProPreview
Q3-2019Nov 6, 2019ProPreview
Q2-2019Aug 6, 2019ProPreview
Q1-2019May 8, 2019ProPreview
Q4-2018Mar 4, 2019ProPreview
Q3-2018Nov 6, 2018ProPreview
Q2-2018Aug 7, 2018ProPreview
Q1-2018May 8, 2018ProPreview
Q4-2017Feb 27, 2018ProPreview
Q3-2017Nov 7, 2017ProPreview
Q2-2017Aug 7, 2017ProPreview
Q1-2017May 4, 2017ProPreview
Q4-2016Feb 27, 2017ProPreview
Q3-2016Nov 7, 2016ProPreview
Q2-2016Aug 4, 2016ProPreview
Q1-2016May 5, 2016ProPreview
Q4-2015Feb 23, 2016ProPreview
Q3-2015Nov 5, 2015ProPreview
Q2-2015Aug 7, 2015ProPreview
Q1-2015May 8, 2015ProPreview
Q4-2014Feb 18, 2015ProPreview
Q3-2014Nov 6, 2014ProPreview
Q2-2014Aug 5, 2014ProPreview
Q1-2014May 8, 2014ProPreview
Q4-2013Feb 26, 2014ProPreview
Q3-2013Nov 5, 2013ProPreview
Q2-2013Aug 8, 2013ProPreview
Q1-2013May 7, 2013ProPreview
Q4-2012Feb 19, 2013ProPreview
Q3-2012Nov 8, 2012ProPreview
Q2-2012Aug 2, 2012ProPreview
Q1-2012May 7, 2012ProPreview
Q4-2011Feb 16, 2012ProPreview
Q3-2011Nov 2, 2011ProPreview
Q2-2011Aug 4, 2011ProPreview
Q1-2011May 4, 2011ProPreview
Q4-2010Feb 10, 2011ProPreview
Q3-2010Oct 28, 2010ProPreview
Q2-2010Aug 5, 2010ProPreview
Q1-2010Apr 28, 2010ProPreview
Q4-2009Feb 4, 2010ProPreview
Q3-2009Oct 29, 2009ProPreview
Q2-2009Jul 30, 2009ProPreview
Q1-2009May 8, 2009ProPreview
Q4-2008Feb 6, 2009ProPreview
Q3-2008Oct 31, 2008ProPreview
Q2-2008Aug 7, 2008ProPreview
Q1-2008May 8, 2008ProPreview
Q4-2007Mar 4, 2008ProPreview
Q3-2007Nov 8, 2007ProPreview